ANALYST-DRIVEN DRUG SALES & REBATE INSIGHTS
IPD's Market & Financial Insights + subscription includes Rebate Monitor, our newest analyst-driven resource for evaluating historical gross-to-net sales, estimated rebates, and supply chain discounts across drugs, competitive landscapes, manufacturer portfolios, and therapeutic areas.
Gain access to analyst-driven rebating and discounting insights
View fully transparent sales and estimated rebate information curated by IPD’s analysts and an external panel of industry trade relations experts utilizing multiple information sources, including manufacturer-reported sales data (earnings reports, presentations,
and transcripts) and third-party utilization data.
View information you can trust
See true-to-market sales and estimated rebate information that accounts for commonly underreported values across products and classes. IPD’s analysts align information with market realities, triangulating and approximating utilization, identifying discount drivers by line of business, and providing underlying methodologies for an in-depth look behind the numbers.
Evaluate competitive landscapes and market dynamics across common time frames
Spot trends, monitor changes, understand market evolution over time, and deliver relevant information to key stakeholders within your organization with easy-to-use rebate change tracking and competitive landscape dashboards, showing current and historical quarterly and yearly estimated rebate information.
Get a holistic picture with IPD's powerful 360° view
Analyze a product from every angle with IPD’s 360° view, which shows a product’s in-depth sales and rebate history, including estimated gross sales, net sales, brand price, estimated rebate, estimated supply chain discount, and total discount.